{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:43:41Z","timestamp":1787870621527,"version":"build-2784847793"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04467-6","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:56:05Z","timestamp":1771606565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanistic insights and clinical implications of RNA-binding proteins in prostate cancer"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1675-7195","authenticated-orcid":false,"given":"Sepide","family":"Javankiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Khodarahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9266-118X","authenticated-orcid":false,"given":"Foroozan","family":"Yarahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5135-0014","authenticated-orcid":false,"given":"Seyedeh Tarlan","family":"Mirzohreh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3905-6589","authenticated-orcid":false,"given":"Saman","family":"Soltani Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6910-8095","authenticated-orcid":false,"given":"Pegah","family":"Kavousinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7837-0624","authenticated-orcid":false,"given":"Sadegh","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8679-5307","authenticated-orcid":false,"given":"Nahal","family":"Aghajamal Avval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8448-228X","authenticated-orcid":false,"given":"Mandana","family":"Baghdadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8398-0643","authenticated-orcid":false,"given":"Nasibeh","family":"Sargazi Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3694-093X","authenticated-orcid":false,"given":"Mahyar","family":"Khanlari Goodarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7158-5129","authenticated-orcid":false,"given":"Neda","family":"Zamen Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6819-0101","authenticated-orcid":false,"given":"Faeze","family":"Ahmadi Beni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5217-924X","authenticated-orcid":false,"given":"Qumars","family":"Behfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"issue":"10","key":"4467_CR1","first-page":"e70016","volume":"7","author":"TK Wilson","year":"2024","unstructured":"Wilson TK, Zishiri OT. Prostate cancer: A review of Genetics, current biomarkers and personalised treatments. Cancer Rep (Hoboken). 2024;7(10):e70016.","journal-title":"Cancer Rep (Hoboken)"},{"issue":"1","key":"4467_CR2","doi-asserted-by":"publisher","first-page":"30728","DOI":"10.1038\/s41598-025-16160-9","volume":"15","author":"H Chen","year":"2025","unstructured":"Chen H, et al. Severe and enduring prostate cancer burden attributable to smoking among old men amid global decline and socioeconomic disparities. Sci Rep. 2025;15(1):30728.","journal-title":"Sci Rep"},{"issue":"2","key":"4467_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.euo.2024.11.010","volume":"8","author":"IO Ola","year":"2025","unstructured":"Ola IO, et al. Long-term risk of prostate cancer mortality among men with baseline prostate-specific antigen below 3 ng\/ml: evidence from the Finnish randomized study of screening for prostate cancer. Eur Urol Oncol. 2025;8(2):452\u20139.","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"4467_CR4","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, et al. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"4467_CR5","doi-asserted-by":"publisher","first-page":"591667","DOI":"10.3389\/fgene.2020.591667","volume":"11","author":"X Hua","year":"2020","unstructured":"Hua X, et al. Effects of RNA binding proteins on the prognosis and malignant progression in prostate cancer. Front Genet. 2020;11:591667.","journal-title":"Front Genet"},{"issue":"10305","key":"4467_CR6","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","volume":"398","author":"S Sandhu","year":"2021","unstructured":"Sandhu S, et al. Prostate cancer. Lancet. 2021;398(10305):1075\u201390.","journal-title":"Lancet"},{"issue":"17","key":"4467_CR7","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, et al. Prostate cancer review: Genetics, Diagnosis, treatment Options, and alternative approaches. Molecules. 2022;27(17):5730.","journal-title":"Molecules"},{"issue":"5","key":"4467_CR8","doi-asserted-by":"publisher","first-page":"e1353855","DOI":"10.1080\/23723556.2017.1353855","volume":"4","author":"T Fei","year":"2017","unstructured":"Fei T. Targeting RNA binding protein in prostate cancer. Mol Cell Oncol. 2017;4(5):e1353855.","journal-title":"Mol Cell Oncol"},{"issue":"3","key":"4467_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/biology14030256","volume":"14","author":"R Rossi","year":"2025","unstructured":"Rossi R, et al. Uncovering new biomarkers for prostate cancer through proteomic and network analysis. Biology. 2025;14(3):256.","journal-title":"Biology"},{"issue":"7","key":"4467_CR10","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1080\/15476286.2020.1809186","volume":"18","author":"S Prashad","year":"2021","unstructured":"Prashad S, Gopal PP. RNA-binding proteins in neurological development and disease. RNA Biol. 2021;18(7):972\u201387.","journal-title":"RNA Biol"},{"key":"4467_CR11","doi-asserted-by":"publisher","first-page":"953880","DOI":"10.3389\/fphys.2022.953880","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, et al. Post-transcriptional control by RNA-binding proteins in diabetes and its related complications. Front Physiol. 2022;13:953880.","journal-title":"Front Physiol"},{"issue":"6","key":"4467_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41569-023-00958-z","volume":"21","author":"M V\u00f6lkers","year":"2024","unstructured":"V\u00f6lkers M, Preiss T, Hentze MW. RNA-binding proteins in cardiovascular biology and disease: the beat goes on. Nat Reviews Cardiol. 2024;21(6):361\u201378.","journal-title":"Nat Reviews Cardiol"},{"issue":"1","key":"4467_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s44324-024-00044-z","volume":"3","author":"E Koletsou","year":"2025","unstructured":"Koletsou E, Huppertz I. RNA-binding proteins as versatile metabolic regulators. Npj Metabolic Health Disease. 2025;3(1):1.","journal-title":"Npj Metabolic Health Disease"},{"issue":"1","key":"4467_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15476286.2025.2470511","volume":"22","author":"J Jungfleisch","year":"2025","unstructured":"Jungfleisch J, Gebauer F. RNA-binding proteins as therapeutic targets in cancer. RNA Biol. 2025;22(1):1\u20138.","journal-title":"RNA Biol"},{"issue":"1","key":"4467_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molcel.2020.03.011","volume":"78","author":"M Corley","year":"2020","unstructured":"Corley M, Burns MC, Yeo GW. How RNA-Binding proteins interact with RNA: molecules and mechanisms. Mol Cell. 2020;78(1):9\u201329.","journal-title":"Mol Cell"},{"issue":"3","key":"4467_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41576-020-00302-y","volume":"22","author":"F Gebauer","year":"2021","unstructured":"Gebauer F, et al. RNA-binding proteins in human genetic disease. Nat Rev Genet. 2021;22(3):185\u201398.","journal-title":"Nat Rev Genet"},{"issue":"7","key":"4467_CR17","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1128\/MCB.01683-13","volume":"34","author":"HK Kini","year":"2014","unstructured":"Kini HK, Kong J, Liebhaber SA. Cytoplasmic poly(A) binding protein C4 serves a critical role in erythroid differentiation. Mol Cell Biol. 2014;34(7):1300\u20139.","journal-title":"Mol Cell Biol"},{"key":"4467_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.freeradbiomed.2014.12.013","volume":"79","author":"J Shang","year":"2015","unstructured":"Shang J, et al. Identification of NOD2 as a novel target of RNA-binding protein hur: evidence from NADPH oxidase-mediated HuR signaling in diabetic nephropathy. Free Radic Biol Med. 2015;79:217\u201327.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"4467_CR19","doi-asserted-by":"publisher","first-page":"16922","DOI":"10.1038\/s41598-019-53097-2","volume":"9","author":"C-Y Cho","year":"2019","unstructured":"Cho C-Y, et al. PTBP1-mediated regulation of AXL mRNA stability plays a role in lung tumorigenesis. Sci Rep. 2019;9(1):16922.","journal-title":"Sci Rep"},{"issue":"11","key":"4467_CR20","doi-asserted-by":"publisher","first-page":"e22281","DOI":"10.1016\/j.heliyon.2023.e22281","volume":"9","author":"A Siddiqui","year":"2023","unstructured":"Siddiqui A, et al. RNA binding proteins PTBP1 and HNRNPL regulate CFTR mRNA decay. Heliyon. 2023;9(11):e22281.","journal-title":"Heliyon"},{"issue":"1","key":"4467_CR21","doi-asserted-by":"publisher","first-page":"7883","DOI":"10.1038\/s41598-025-92351-8","volume":"15","author":"L Guo","year":"2025","unstructured":"Guo L, et al. The RNA-binding protein LARP6 regulates the alternative splicing of related genes in MDA-MB-231 cells. Sci Rep. 2025;15(1):7883.","journal-title":"Sci Rep"},{"issue":"1","key":"4467_CR22","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1038\/s41467-023-39936-x","volume":"14","author":"M Mullari","year":"2023","unstructured":"Mullari M, et al. Characterising the RNA-binding protein atlas of the mammalian brain uncovers RBM5 misregulation in mouse models of huntington\u2019s disease. Nat Commun. 2023;14(1):4348.","journal-title":"Nat Commun"},{"issue":"1","key":"4467_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41419-022-04524-2","volume":"13","author":"S Sun","year":"2022","unstructured":"Sun S, et al. RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m6A-dependent manner. Cell Death Dis. 2022;13(1):73.","journal-title":"Cell Death Dis"},{"key":"4467_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fmolb.2019.00161","volume":"6","author":"MP Thelen","year":"2019","unstructured":"Thelen MP, Kye MJ. The role of RNA binding proteins for local mRNA translation: implications in neurological disorders. Front Mol Biosci. 2019;6:161.","journal-title":"Front Mol Biosci"},{"issue":"7067","key":"4467_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature04115","volume":"438","author":"S H\u00fcttelmaier","year":"2005","unstructured":"H\u00fcttelmaier S, et al. Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1. Nature. 2005;438(7067):512\u20135.","journal-title":"Nature"},{"issue":"9","key":"4467_CR26","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.neuron.2022.01.035","volume":"110","author":"AB Harbauer","year":"2022","unstructured":"Harbauer AB, et al. Neuronal mitochondria transport Pink1 mRNA via Synaptojanin 2 to support local mitophagy. Neuron. 2022;110(9):1516\u2013e15319.","journal-title":"Neuron"},{"issue":"22","key":"4467_CR27","doi-asserted-by":"publisher","first-page":"peadn2050","DOI":"10.1126\/sciadv.adn2050","volume":"10","author":"M Zaninello","year":"2024","unstructured":"Zaninello M, et al. CLUH maintains functional mitochondria and translation in motoneuronal axons and prevents peripheral neuropathy. Sci Adv. 2024;10(22):peadn2050.","journal-title":"Sci Adv"},{"issue":"9","key":"4467_CR28","doi-asserted-by":"publisher","first-page":"14201","DOI":"10.1002\/jcb.28851","volume":"120","author":"A Batool","year":"2019","unstructured":"Batool A, Aashaq S, Andrabi KI. Eukaryotic initiation factor 4E (eIF4E): A recap of the cap-binding protein. J Cell Biochem. 2019;120(9):14201\u201312.","journal-title":"J Cell Biochem"},{"issue":"1","key":"4467_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/emboj.2008.259","volume":"28","author":"YV Svitkin","year":"2009","unstructured":"Svitkin YV, et al. General RNA-binding proteins have a function in poly(A)-binding protein-dependent translation. Embo J. 2009;28(1):58\u201368.","journal-title":"Embo J"},{"issue":"3","key":"4467_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.molcel.2014.03.023","volume":"54","author":"E Chen","year":"2014","unstructured":"Chen E, et al. Fragile X mental retardation protein regulates translation by binding directly to the ribosome. Mol Cell. 2014;54(3):407\u201317.","journal-title":"Mol Cell"},{"issue":"5","key":"4467_CR31","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.molcel.2011.05.006","volume":"42","author":"RS Muddashetty","year":"2011","unstructured":"Muddashetty RS, et al. Reversible Inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Mol Cell. 2011;42(5):673\u201388.","journal-title":"Mol Cell"},{"issue":"7","key":"4467_CR32","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41590-025-02183-x","volume":"26","author":"Z Yu","year":"2025","unstructured":"Yu Z, et al. The RNA-binding E3 ligase MKRN2 selectively disrupts Il6 translation to restrain inflammation. Nat Immunol. 2025;26(7):1036\u201347.","journal-title":"Nat Immunol"},{"issue":"4","key":"4467_CR33","doi-asserted-by":"publisher","first-page":"101493","DOI":"10.1016\/j.gendis.2024.101493","volume":"12","author":"Y Jia","year":"2025","unstructured":"Jia Y, et al. The role of RNA binding proteins in cancer biology: a focus on FMRP. Genes Dis. 2025;12(4):101493.","journal-title":"Genes Dis"},{"issue":"11","key":"4467_CR34","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41419-022-05391-7","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, et al. FMR1 promotes the progression of colorectal cancer cell by stabilizing EGFR mRNA in an m6A-dependent manner. Cell Death Dis. 2022;13(11):941.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4467_CR35","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1038\/s41598-024-62681-0","volume":"14","author":"Y Mi","year":"2024","unstructured":"Mi Y, et al. Genome-wide identification and analysis of epithelial-mesenchymal transition-related RNA-binding proteins and alternative splicing in a human breast cancer cell line. Sci Rep. 2024;14(1):11753.","journal-title":"Sci Rep"},{"issue":"1","key":"4467_CR36","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1038\/s41467-024-47031-y","volume":"15","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, et al. Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma. Nat Commun. 2024;15(1):2810.","journal-title":"Nat Commun"},{"issue":"1","key":"4467_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1182\/blood.2020009676","volume":"138","author":"M Feng","year":"2021","unstructured":"Feng M, et al. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner. Blood. 2021;138(1):71\u201385.","journal-title":"Blood"},{"issue":"1","key":"4467_CR38","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1038\/s41467-022-31818-y","volume":"13","author":"M Cort\u00e9s-L\u00f3pez","year":"2022","unstructured":"Cort\u00e9s-L\u00f3pez M, et al. High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance. Nat Commun. 2022;13(1):5570.","journal-title":"Nat Commun"},{"issue":"1","key":"4467_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41419-025-07926-0","volume":"16","author":"X Li","year":"2025","unstructured":"Li X, et al. The RNA-binding protein CELF1 targets ATG5 to regulate autophagy and promote drug resistance in acute myeloid leukemia. Cell Death Dis. 2025;16(1):599.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4467_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41420-025-02316-z","volume":"11","author":"S Peng","year":"2025","unstructured":"Peng S, et al. Regulatory roles of RNA binding proteins in the Hippo pathway. Cell Death Discovery. 2025;11(1):36.","journal-title":"Cell Death Discovery"},{"issue":"1","key":"4467_CR41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-020-01161-1","volume":"19","author":"D Jin","year":"2020","unstructured":"Jin D, et al. m(6)A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107\/LATS2-mediated YAP activity in NSCLC. Mol Cancer. 2020;19(1):40.","journal-title":"Mol Cancer"},{"issue":"11","key":"4467_CR42","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/s41388-022-02198-w","volume":"41","author":"H Zou","year":"2022","unstructured":"Zou H, et al. RNA-binding protein complex LIN28\/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7. Oncogene. 2022;41(11):1657\u201372.","journal-title":"Oncogene"},{"key":"4467_CR43","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.omtn.2021.07.012","volume":"26","author":"T Liu","year":"2021","unstructured":"Liu T, et al. The RNA binding protein QKI5 suppresses ovarian cancer via downregulating transcriptional coactivator TAZ. Mol Ther Nucleic Acids. 2021;26:388\u2013400.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"9","key":"4467_CR44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12032-020-01384-8","volume":"37","author":"H Yang","year":"2020","unstructured":"Yang H, et al. RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer. Med Oncol. 2020;37(9):84.","journal-title":"Med Oncol"},{"issue":"3","key":"4467_CR45","doi-asserted-by":"publisher","first-page":"e104895","DOI":"10.15252\/embj.2020104895","volume":"40","author":"D Srivastava","year":"2021","unstructured":"Srivastava D, et al. Modulation of yorkie activity by alternative splicing is required for developmental stability. Embo J. 2021;40(3):e104895.","journal-title":"Embo J"},{"issue":"15","key":"4467_CR46","doi-asserted-by":"publisher","first-page":"8658","DOI":"10.1093\/nar\/gkac509","volume":"50","author":"S Choi","year":"2022","unstructured":"Choi S, et al. RBFOX2-regulated TEAD1 alternative splicing plays a pivotal role in Hippo-YAP signaling. Nucleic Acids Res. 2022;50(15):8658\u201373.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"4467_CR47","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1158\/0008-5472.CAN-10-1605","volume":"71","author":"H Cai","year":"2011","unstructured":"Cai H, et al. Invasive prostate carcinoma driven by c-Src and androgen receptor synergy. Cancer Res. 2011;71(3):862\u201372.","journal-title":"Cancer Res"},{"key":"4467_CR48","doi-asserted-by":"publisher","first-page":"528954","DOI":"10.1155\/2015\/528954","volume":"2015","author":"P Frisone","year":"2015","unstructured":"Frisone P, et al. SAM68: signal transduction and RNA metabolism in human cancer. Biomed Res Int. 2015;2015:528954.","journal-title":"Biomed Res Int"},{"issue":"30","key":"4467_CR49","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1038\/sj.onc.1210224","volume":"26","author":"R Bus\u00e0","year":"2007","unstructured":"Bus\u00e0 R, et al. The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells. Oncogene. 2007;26(30):4372\u201382.","journal-title":"Oncogene"},{"issue":"11","key":"4467_CR50","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/s41594-022-00853-0","volume":"29","author":"M Pieraccioli","year":"2022","unstructured":"Pieraccioli M, et al. The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer. Nat Struct Mol Biol. 2022;29(11):1101\u201312.","journal-title":"Nat Struct Mol Biol"},{"issue":"27","key":"4467_CR51","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1038\/sj.onc.1206465","volume":"22","author":"JJ Derry","year":"2003","unstructured":"Derry JJ, et al. Altered localization and activity of the intracellular tyrosine kinase BRK\/Sik in prostate tumor cells. Oncogene. 2003;22(27):4212\u201320.","journal-title":"Oncogene"},{"issue":"1","key":"4467_CR52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/path.2324","volume":"215","author":"P Rajan","year":"2008","unstructured":"Rajan P, et al. The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor. J Pathol. 2008;215(1):67\u201377.","journal-title":"J Pathol"},{"issue":"5","key":"4467_CR53","doi-asserted-by":"publisher","first-page":"382","DOI":"10.2174\/1568009618666181031145953","volume":"19","author":"M Wu","year":"2019","unstructured":"Wu M, et al. The RNA binding protein hur: A promising drug target for anticancer therapy. Curr Cancer Drug Targets. 2019;19(5):382\u201399.","journal-title":"Curr Cancer Drug Targets"},{"issue":"8","key":"4467_CR54","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/cells8080797","volume":"8","author":"W Eberhardt","year":"2019","unstructured":"Eberhardt W, Nasrullah U, Haeussler K. Inhibition of caspase-2 translation by the mRNA binding protein HuR: a novel path of therapy resistance in colon carcinoma cells? Cells. 2019;8(8):797.","journal-title":"Cells"},{"issue":"30","key":"4467_CR55","doi-asserted-by":"publisher","first-page":"27183","DOI":"10.1074\/jbc.M202883200","volume":"277","author":"BB Yeap","year":"2002","unstructured":"Yeap BB, et al. Novel binding of HuR and poly(C)-binding protein to a conserved UC-rich motif within the 3\u2019-untranslated region of the androgen receptor messenger RNA. J Biol Chem. 2002;277(30):27183\u201392.","journal-title":"J Biol Chem"},{"issue":"1","key":"4467_CR56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.eururo.2008.04.043","volume":"56","author":"F Barbisan","year":"2009","unstructured":"Barbisan F, et al. Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in Atrophy, High-grade prostatic intraepithelial Neoplasia, and incidental prostate cancer in cystoprostatectomies. Eur Urol. 2009;56(1):105\u201312.","journal-title":"Eur Urol"},{"issue":"1","key":"4467_CR57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Therapy. 2024;9(1):55.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"4467_CR58","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1186\/s12964-024-01916-z","volume":"22","author":"L Wei","year":"2024","unstructured":"Wei L, et al. RNA-binding protein HuR Inhibition induces multiple programmed cell death in breast and prostate cancer. Cell Commun Signal. 2024;22(1):580.","journal-title":"Cell Commun Signal"},{"key":"4467_CR59","doi-asserted-by":"publisher","first-page":"988290","DOI":"10.3389\/fonc.2022.988290","volume":"12","author":"X Nong","year":"2022","unstructured":"Nong X, et al. The mechanism of branched-chain amino acid transferases in different diseases: research progress and future prospects. Front Oncol. 2022;12:988290.","journal-title":"Front Oncol"},{"issue":"1","key":"4467_CR60","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12967-024-04970-w","volume":"22","author":"H You","year":"2024","unstructured":"You H, et al. HuR promotes castration-resistant prostate cancer progression by altering ERK5 activation via posttranscriptional regulation of BCAT1. J Transl Med. 2024;22(1):178.","journal-title":"J Transl Med"},{"key":"4467_CR61","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.trsl.2016.04.002","volume":"175","author":"K Mitsunari","year":"2016","unstructured":"Mitsunari K, et al. Human antigen R is positively associated with malignant aggressiveness via upregulation of cell proliferation, migration, and vascular endothelial growth factors and cyclooxygenase-2 in prostate cancer. Transl Res. 2016;175:116\u201328.","journal-title":"Transl Res"},{"issue":"3","key":"4467_CR62","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1089\/dna.2017.3940","volume":"37","author":"H Liu","year":"2018","unstructured":"Liu H, et al. Posttranscriptional regulation of human antigen R by miR-133b enhances docetaxel cytotoxicity through the Inhibition of ATP-Binding cassette subfamily G member 2 in prostate cancer cells. DNA Cell Biol. 2018;37(3):210\u20139.","journal-title":"DNA Cell Biol"},{"issue":"2","key":"4467_CR63","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3892\/mmr.2025.13574","volume":"32","author":"D Wu","year":"2025","unstructured":"Wu D, Dong S, Zhou W. Insulin\u2013like growth factor in cancer: new perspectives (Review). Mol Med Rep. 2025;32(2):209.","journal-title":"Mol Med Rep"},{"issue":"4","key":"4467_CR64","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3390\/cancers15041287","volume":"15","author":"G Liu","year":"2023","unstructured":"Liu G, et al. Emerging role of IGF-1 in prostate cancer: a promising biomarker and therapeutic target. Cancers (Basel). 2023;15(4):1287.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"4467_CR65","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/cells9051261","volume":"9","author":"Q Cai","year":"2020","unstructured":"Cai Q, Dozmorov M, Oh Y. IGFBP-3\/IGFBP-3 receptor system as an anti-tumor and anti-metastatic signaling in cancer. Cells. 2020;9(5):1261.","journal-title":"Cells"},{"issue":"1","key":"4467_CR66","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1186\/s12885-020-07310-5","volume":"20","author":"K Igarashi","year":"2020","unstructured":"Igarashi K, et al. Molecular evidence of IGFBP-3 dependent and independent VD3 action and its nonlinear response on IGFBP-3 induction in prostate cancer cells. BMC Cancer. 2020;20(1):802.","journal-title":"BMC Cancer"},{"issue":"3","key":"4467_CR67","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ghir.2003.12.009","volume":"14","author":"ML Shim","year":"2004","unstructured":"Shim ML, et al. Insulin-like growth factor binding protein-3 is a novel mediator of apoptosis in insulin-secreting cells. Growth Hormone IGF Res. 2004;14(3):216\u201325.","journal-title":"Growth Hormone IGF Res"},{"issue":"43","key":"4467_CR68","doi-asserted-by":"publisher","first-page":"33607","DOI":"10.1074\/jbc.M002547200","volume":"275","author":"B Liu","year":"2000","unstructured":"Liu B, et al. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem. 2000;275(43):33607\u201313.","journal-title":"J Biol Chem"},{"key":"4467_CR69","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cytogfr.2023.06.002","volume":"71\u201372","author":"Y Xie","year":"2023","unstructured":"Xie Y, et al. mTOR in programmed cell death and its therapeutic implications. Cytokine Growth Factor Rev. 2023;71\u201372:66\u201381.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"4467_CR70","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/cancers15010017","volume":"15","author":"M Grzmil","year":"2022","unstructured":"Grzmil M, et al. Targeting mTORC1 activity to improve efficacy of radioligand therapy in cancer. Cancers (Basel). 2022;15(1):17.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"4467_CR71","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41419-024-07077-8","volume":"15","author":"B Son","year":"2024","unstructured":"Son B, et al. Targeted therapy of cancer stem cells: Inhibition of mTOR in pre-clinical and clinical research. Cell Death Dis. 2024;15(9):696.","journal-title":"Cell Death Dis"},{"issue":"5","key":"4467_CR72","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.3892\/or.2015.4201","volume":"34","author":"Y Du","year":"2015","unstructured":"Du Y, et al. Insulin-like growth factor binding protein-3 mediates interleukin-24-induced apoptosis through Inhibition of the mTOR pathway in prostate cancer. Oncol Rep. 2015;34(5):2273\u201381.","journal-title":"Oncol Rep"},{"key":"4467_CR73","doi-asserted-by":"publisher","first-page":"101253","DOI":"10.1016\/j.currproblcancer.2025.101253","volume":"59","author":"B Ecer","year":"2025","unstructured":"Ecer B, et al. Angiogenesis biomarkers in prostate cancer: unlocking new avenues for prognosis and diagnosis. Curr Probl Cancer. 2025;59:101253.","journal-title":"Curr Probl Cancer"},{"issue":"2","key":"4467_CR74","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1096\/fj.201902168RR","volume":"34","author":"HJ Zhao","year":"2020","unstructured":"Zhao HJ, et al. Bone morphogenetic protein 2 promotes human trophoblast cell invasion and endothelial-like tube formation through ID1-mediated upregulation of IGF binding protein-3. Faseb J. 2020;34(2):3151\u201364.","journal-title":"Faseb J"},{"issue":"4","key":"4467_CR75","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/j.1538-7836.2007.02431.x","volume":"5","author":"R Granata","year":"2007","unstructured":"Granata R, et al. Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms. J Thromb Haemost. 2007;5(4):835\u201345.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"4467_CR76","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3892\/ijo.2024.5608","volume":"64","author":"K Zhong","year":"2024","unstructured":"Zhong K, et al. CDK12 regulates angiogenesis of advanced prostate cancer by IGFBP3. Int J Oncol. 2024;64(2):20.","journal-title":"Int J Oncol"},{"issue":"15","key":"4467_CR77","doi-asserted-by":"publisher","first-page":"5154","DOI":"10.1158\/0008-5472.CAN-10-4513","volume":"71","author":"HH Mehta","year":"2011","unstructured":"Mehta HH, et al. IGFBP-3 is a metastasis suppression gene in prostate cancer. Cancer Res. 2011;71(15):5154\u201363.","journal-title":"Cancer Res"},{"issue":"1","key":"4467_CR78","doi-asserted-by":"publisher","first-page":"18003","DOI":"10.1038\/s41598-021-97190-x","volume":"11","author":"DJ Beveridge","year":"2021","unstructured":"Beveridge DJ, et al. The tumor suppressor miR-642a-5p targets Wilms tumor 1 gene and cell-cycle progression in prostate cancer. Sci Rep. 2021;11(1):18003.","journal-title":"Sci Rep"},{"issue":"2","key":"4467_CR79","doi-asserted-by":"publisher","first-page":"108984","DOI":"10.1016\/j.isci.2024.108984","volume":"27","author":"AR Leslie","year":"2024","unstructured":"Leslie AR, et al. IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer. iScience. 2024;27(2):108984.","journal-title":"iScience"},{"issue":"1","key":"4467_CR80","doi-asserted-by":"publisher","first-page":"2443046","DOI":"10.1080\/07853890.2024.2443046","volume":"57","author":"W Zhu","year":"2025","unstructured":"Zhu W, et al. RNA-binding protein quaking: a multifunctional regulator in tumour progression. Ann Med. 2025;57(1):2443046.","journal-title":"Ann Med"},{"issue":"4","key":"4467_CR81","doi-asserted-by":"publisher","first-page":"e1004289","DOI":"10.1371\/journal.pgen.1004289","volume":"10","author":"FY Zong","year":"2014","unstructured":"Zong FY, et al. The RNA-binding protein QKI suppresses cancer-associated aberrant splicing. PLoS Genet. 2014;10(4):e1004289.","journal-title":"PLoS Genet"},{"issue":"6","key":"4467_CR82","doi-asserted-by":"publisher","first-page":"e1724","DOI":"10.1002\/wrna.1724","volume":"13","author":"DP Neumann","year":"2022","unstructured":"Neumann DP, Goodall GJ, Gregory PA. The quaking RNA-binding proteins as regulators of cell differentiation. Wiley Interdiscip Rev RNA. 2022;13(6):e1724.","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"1","key":"4467_CR83","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4161\/cbt.26722","volume":"15","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, et al. The tumor suppressing effects of QKI-5 in prostate cancer: a novel diagnostic and prognostic protein. Cancer Biol Ther. 2014;15(1):108\u201318.","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"4467_CR84","first-page":"8203","volume":"17","author":"K Zhang","year":"2018","unstructured":"Zhang K, et al. Androgen receptor\u2013mediated upregulation of quaking affects androgen receptor\u2013related prostate cancer development and anti\u2013androgen receptor therapy. Mol Med Rep. 2018;17(6):8203\u201311.","journal-title":"Mol Med Rep"},{"issue":"1","key":"4467_CR85","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jcmm.13658","volume":"23","author":"M Wu","year":"2019","unstructured":"Wu M, et al. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p\/QKI-5 axis. J Cell Mol Med. 2019;23(1):29\u201338.","journal-title":"J Cell Mol Med"},{"key":"4467_CR86","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12935-019-0835-9","volume":"19","author":"TS Vieira-Silva","year":"2019","unstructured":"Vieira-Silva TS, et al. Histone variant MacroH2A1 is downregulated in prostate cancer and influences malignant cell phenotype. Cancer Cell Int. 2019;19:112.","journal-title":"Cancer Cell Int"},{"key":"4467_CR87","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.canlet.2020.07.040","volume":"495","author":"D Chen","year":"2020","unstructured":"Chen D, et al. Targeting the radiation-induced TR4 nuclear receptor-mediated QKI\/circZEB1\/miR-141-3p\/ZEB1 signaling increases prostate cancer radiosensitivity. Cancer Lett. 2020;495:100\u201311.","journal-title":"Cancer Lett"},{"issue":"1","key":"4467_CR88","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41420-024-02198-7","volume":"10","author":"B Li","year":"2024","unstructured":"Li B, et al. Regulation of HNRNP family by post-translational modifications in cancer. Cell Death Discovery. 2024;10(1):427.","journal-title":"Cell Death Discovery"},{"issue":"28","key":"4467_CR89","doi-asserted-by":"publisher","first-page":"e2220190120","DOI":"10.1073\/pnas.2220190120","volume":"120","author":"X Chen","year":"2023","unstructured":"Chen X, et al. The RNA-binding proteins HnRNP H and F regulate splicing of a MYC-dependent HRAS exon in prostate cancer cells. Proc Natl Acad Sci U S A. 2023;120(28):e2220190120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"4467_CR90","doi-asserted-by":"publisher","first-page":"19342","DOI":"10.18632\/oncotarget.14258","volume":"8","author":"X Zhou","year":"2017","unstructured":"Zhou X, et al. HnRNP-L promotes prostate cancer progression by enhancing cell cycling and inhibiting apoptosis. Oncotarget. 2017;8(12):19342\u201353.","journal-title":"Oncotarget"},{"key":"4467_CR91","doi-asserted-by":"publisher","first-page":"1419806","DOI":"10.3389\/fphar.2024.1419806","volume":"15","author":"NJ Kurganovs","year":"2024","unstructured":"Kurganovs NJ, Engedal N. To eat or not to eat: a critical review on the role of autophagy in prostate carcinogenesis and prostate cancer therapeutics. Front Pharmacol. 2024;15:1419806.","journal-title":"Front Pharmacol"},{"key":"4467_CR92","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.omtn.2021.10.006","volume":"26","author":"J Lu","year":"2021","unstructured":"Lu J, et al. HnRNP-L-regulated circCSPP1\/miR-520\u00a0h\/EGR1 axis modulates autophagy and promotes progression in prostate cancer. Mol Ther Nucleic Acids. 2021;26:927\u201344.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"null","key":"4467_CR93","doi-asserted-by":"publisher","first-page":"7263","DOI":"10.2147\/CMAR.S330713","volume":"13","author":"S Wang","year":"2021","unstructured":"Wang S, et al. HNRNPC promotes Proliferation, metastasis and predicts prognosis in prostate cancer. Cancer Manage Res. 2021;13(null):7263\u201376.","journal-title":"Cancer Manage Res"},{"issue":"12","key":"4467_CR94","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1158\/1535-7163.MCT-17-0030","volume":"16","author":"R Tummala","year":"2017","unstructured":"Tummala R, et al. Quercetin targets hnRNPA1 to overcome enzalutamide resistance in prostate cancer cells. Mol Cancer Ther. 2017;16(12):2770\u20139.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"4467_CR95","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1159\/000492315","volume":"48","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, et al. The RNA-Binding protein PCBP1 functions as a tumor suppressor in prostate cancer by inhibiting mitogen activated protein kinase 1. Cell Physiol Biochem. 2018;48(4):1747\u201354.","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"4467_CR96","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1158\/0008-5472.CAN-08-2308","volume":"69","author":"NK Mukhopadhyay","year":"2009","unstructured":"Mukhopadhyay NK, et al. Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translation. Cancer Res. 2009;69(6):2210\u20138.","journal-title":"Cancer Res"},{"issue":"1","key":"4467_CR97","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1186\/s12935-021-02331-x","volume":"21","author":"H-L Wu","year":"2021","unstructured":"Wu H-L, et al. Transcriptional regulation and ubiquitination-dependent regulation of HnRNPK oncogenic function in prostate tumorigenesis. Cancer Cell Int. 2021;21(1):641.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4467_CR98","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12885-021-07844-2","volume":"21","author":"KA Marcellus","year":"2021","unstructured":"Marcellus KA, et al. Distinct roles for the RNA-binding protein Staufen1 in prostate cancer. BMC Cancer. 2021;21(1):120.","journal-title":"BMC Cancer"},{"issue":"6","key":"4467_CR99","doi-asserted-by":"publisher","first-page":"pgad203","DOI":"10.1093\/pnasnexus\/pgad203","volume":"2","author":"K-I Takayama","year":"2023","unstructured":"Takayama K-I, et al. Identification of small-molecule inhibitors against the interaction of RNA-binding protein PSF and its target RNA for cancer treatment. PNAS Nexus. 2023;2(6):pgad203.","journal-title":"PNAS Nexus"},{"issue":"39","key":"4467_CR100","doi-asserted-by":"publisher","first-page":"10461","DOI":"10.1073\/pnas.1706076114","volume":"114","author":"K-i Takayama","year":"2017","unstructured":"Takayama K-i, et al. Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF. Proc Natl Acad Sci. 2017;114(39):10461\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"4467_CR101","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/cas.14280","volume":"111","author":"J Zhao","year":"2020","unstructured":"Zhao J, et al. RNA-binding protein Musashi2 stabilizing androgen receptor drives prostate cancer progression. Cancer Sci. 2020;111(2):369\u201382.","journal-title":"Cancer Sci"},{"issue":"29","key":"4467_CR102","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.2217\/fon-2021-0247","volume":"17","author":"G Shrivastava","year":"2021","unstructured":"Shrivastava G, et al. Targeting LIN28: A new hope in prostate cancer theranostics. Future Oncol. 2021;17(29):3873\u201380.","journal-title":"Future Oncol"},{"issue":"2","key":"4467_CR103","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1074\/jbc.M111.278705","volume":"287","author":"N Nadiminty","year":"2012","unstructured":"Nadiminty N, et al. MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer Cells*. J Biol Chem. 2012;287(2):1527\u201337.","journal-title":"J Biol Chem"},{"key":"4467_CR104","doi-asserted-by":"publisher","first-page":"106407","DOI":"10.1016\/j.jsbmb.2023.106407","volume":"235","author":"K Tsuji","year":"2023","unstructured":"Tsuji K, et al. RNA-binding protein 14 promotes phase separation to sustain prostate specific antigen expression under androgen deprivation in human prostate cancer. J Steroid Biochem Mol Biol. 2023;235:106407.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"4467_CR105","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3390\/ijms24020910","volume":"24","author":"F Lasorsa","year":"2023","unstructured":"Lasorsa F, et al. Emerging hallmarks of metabolic reprogramming in prostate cancer. Int J Mol Sci. 2023;24(2):910.","journal-title":"Int J Mol Sci"},{"issue":"42","key":"4467_CR106","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1038\/s41388-025-03559-x","volume":"44","author":"M Raza","year":"2025","unstructured":"Raza M, et al. ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating Glycolysis. Oncogene. 2025;44(42):4058\u201374.","journal-title":"Oncogene"},{"issue":"1","key":"4467_CR107","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13578-025-01371-4","volume":"15","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, et al. The RNA binding protein CARHSP1 facilitates tumor growth, metastasis and immune escape by enhancing IL-17RA mRNA stabilization in prostate cancer. Cell Biosci. 2025;15(1):33.","journal-title":"Cell Biosci"},{"issue":"2","key":"4467_CR108","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41419-023-05627-0","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang S, et al. RBM3 suppresses stemness remodeling of prostate cancer in bone microenvironment by modulating N6-methyladenosine on CTNNB1 mRNA. Cell Death Dis. 2023;14(2):91.","journal-title":"Cell Death Dis"},{"issue":"7","key":"4467_CR109","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.3390\/ijms19071920","volume":"19","author":"M Capaia","year":"2018","unstructured":"Capaia M, et al. A HnRNP K\u207bAR-related signature reflects progression toward castration-resistant prostate cancer. Int J Mol Sci. 2018;19(7):1920.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4467_CR110","doi-asserted-by":"publisher","first-page":"7794","DOI":"10.1038\/s41467-023-43676-3","volume":"14","author":"Y Ji","year":"2023","unstructured":"Ji Y, et al. The ELAVL3\/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer. Nat Commun. 2023;14(1):7794.","journal-title":"Nat Commun"},{"issue":"45","key":"4467_CR111","doi-asserted-by":"publisher","first-page":"28092","DOI":"10.1073\/pnas.2008479117","volume":"117","author":"JE Vellky","year":"2020","unstructured":"Vellky JE, et al. RNA-binding protein DDX3 mediates posttranscriptional regulation of androgen receptor: A mechanism of castration resistance. Proc Natl Acad Sci U S A. 2020;117(45):28092\u2013101.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"4467_CR112","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.ccell.2025.02.027","volume":"43","author":"D Kuzuoglu-Ozturk","year":"2025","unstructured":"Kuzuoglu-Ozturk D, et al. Small-molecule RNA therapeutics to target prostate cancer. Cancer Cell. 2025;43(5):841\u2013e8558.","journal-title":"Cancer Cell"},{"issue":"2","key":"4467_CR113","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.18632\/aging.202387","volume":"13","author":"P Yuan","year":"2021","unstructured":"Yuan P, et al. Identification of RNA-binding protein SNRPA1 for prognosis in prostate cancer. Aging. 2021;13(2):2895\u2013911.","journal-title":"Aging"},{"issue":"1","key":"4467_CR114","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"4467_CR115","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","volume":"87","author":"EJ Schafer","year":"2025","unstructured":"Schafer EJ, et al. Recent patterns and trends in global prostate cancer incidence and mortality: an update. Eur Urol. 2025;87(3):302\u201313.","journal-title":"Eur Urol"},{"issue":"2","key":"4467_CR116","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.eururo.2015.12.054","volume":"70","author":"L Fabris","year":"2016","unstructured":"Fabris L, et al. The potential of MicroRNAs as prostate cancer biomarkers. Eur Urol. 2016;70(2):312\u201322.","journal-title":"Eur Urol"},{"key":"4467_CR117","doi-asserted-by":"publisher","first-page":"117824","DOI":"10.1016\/j.cca.2024.117824","volume":"555","author":"M Samare-Najaf","year":"2024","unstructured":"Samare-Najaf M, et al. Prostate cancer: novel genetic and Immunologic biomarkers. Clin Chim Acta. 2024;555:117824.","journal-title":"Clin Chim Acta"},{"key":"4467_CR118","doi-asserted-by":"publisher","first-page":"1388294","DOI":"10.3389\/fmolb.2024.1388294","volume":"11","author":"U Ala","year":"2024","unstructured":"Ala U, Fagoonee S. RNA-binding protein transcripts as potential biomarkers for detecting primary sclerosing cholangitis and for predicting its progression to cholangiocarcinoma. Front Mol Biosci. 2024;11:1388294.","journal-title":"Front Mol Biosci"},{"key":"4467_CR119","doi-asserted-by":"publisher","first-page":"591667","DOI":"10.3389\/fgene.2020.591667","volume":"11","author":"X Hua","year":"2020","unstructured":"Hua X, et al. Effects of RNA binding proteins on the prognosis and malignant progression in prostate cancer. Front Genet. 2020;11:591667.","journal-title":"Front Genet"},{"issue":"2","key":"4467_CR120","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41391-023-00712-z","volume":"27","author":"ND Shore","year":"2024","unstructured":"Shore ND, et al. Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification. Prostate Cancer Prostatic Dis. 2024;27(2):192\u2013201.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"4467_CR121","doi-asserted-by":"publisher","first-page":"153587","DOI":"10.1016\/j.prp.2021.153587","volume":"225","author":"Q Xing","year":"2021","unstructured":"Xing Q, et al. A novel 13 RNA binding proteins (RBPs) signature could predict prostate cancer biochemical recurrence. Pathol - Res Pract. 2021;225:153587.","journal-title":"Pathol - Res Pract"},{"issue":"7","key":"4467_CR122","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s12094-022-02782-2","volume":"24","author":"Z Wang","year":"2022","unstructured":"Wang Z, et al. A novel immune-related RNA-binding proteins signature to predict survival and therapeutic responses in prostate cancer. Clin Transl Oncol. 2022;24(7):1381\u201394.","journal-title":"Clin Transl Oncol"},{"issue":"17","key":"4467_CR123","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, et al. Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules. 2022;27(17):5730.","journal-title":"Molecules"},{"issue":"3","key":"4467_CR124","first-page":"194","volume":"24","author":"EE Neil","year":"2019","unstructured":"Neil EE, Bisaccia EK. Nusinersen: A novel antisense oligonucleotide for the treatment of spinal muscular atrophy. J Pediatr Pharmacol Ther. 2019;24(3):194\u2013203.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"2","key":"4467_CR125","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/cancers16020384","volume":"16","author":"J Morillo-Bernal","year":"2024","unstructured":"Morillo-Bernal J, et al. HuR (ELAVL1) stabilizes SOX9 mRNA and promotes migration and invasion in breast cancer cells. Cancers (Basel). 2024;16(2):384.","journal-title":"Cancers (Basel)"},{"key":"4467_CR126","doi-asserted-by":"publisher","first-page":"813268","DOI":"10.3389\/fgene.2022.813268","volume":"13","author":"X Ye","year":"2022","unstructured":"Ye X, Fu Q, Xiao H. The role of RNA-Binding protein HuR in lung cancer by RNA sequencing analysis. Front Genet. 2022;13:813268.","journal-title":"Front Genet"},{"issue":"1","key":"4467_CR127","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41420-023-01352-x","volume":"9","author":"Y Cen","year":"2023","unstructured":"Cen Y, et al. Novel roles of RNA-binding proteins in drug resistance of breast cancer: from molecular biology to targeting therapeutics. Cell Death Discovery. 2023;9(1):52.","journal-title":"Cell Death Discovery"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04467-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04467-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04467-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:03:16Z","timestamp":1774620196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04467-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":127,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4467"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04467-6","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"489"}}